Microbot Medical Inc
MBOT2.570USD
+0.020+0.78%
Market hours （ET）Quotes delayed by 15 min
89.29MMarket Cap
LossP/E TTM
More Details of Microbot Medical Inc Company
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
Company Info
Ticker SymbolMBOT
Company nameMicrobot Medical Inc
IPO dateMar 25, 1992
CEOMr. Harel Gadot
Number of employees21
Security typeOrdinary Share
Fiscal year-endMar 25
Address175 Derby St Bld 27
CityHINGHAM
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code02043
Phone17818753605
Websitehttp://www.microbotmedical.com/
Ticker SymbolMBOT
IPO dateMar 25, 1992
CEOMr. Harel Gadot
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
5.05%
Geode Capital Management, L.L.C.
0.78%
BlackRock Institutional Trust Company, N.A.
0.58%
MEDX Ventures Group LLC
0.34%
State Street Global Advisors (US)
0.34%
Other
92.91%
Shareholder Types
Shareholders
Proportion
Investment Advisor
6.96%
Investment Advisor/Hedge Fund
1.74%
Research Firm
0.36%
Venture Capital
0.36%
Hedge Fund
0.26%
Other
90.31%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
93
3.70M
9.69%
-538.67K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
2023Q1
63
2.51M
30.86%
-204.69K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
741.16K
2.04%
+281.62K
+61.28%
Mar 31, 2025
Geode Capital Management, L.L.C.
316.92K
0.87%
+174.26K
+122.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
236.10K
0.65%
+98.73K
+71.87%
Mar 31, 2025
MEDX Ventures Group LLC
136.85K
0.38%
--
--
Apr 15, 2025
State Street Global Advisors (US)
136.67K
0.38%
+110.60K
+424.24%
Mar 31, 2025
DNB Asset Management AS
114.82K
0.32%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
104.18K
0.29%
+74.45K
+250.44%
Mar 31, 2025
Two Sigma Investments, LP
83.02K
0.23%
+72.29K
+673.87%
Mar 31, 2025
Northern Trust Investments, Inc.
71.06K
0.2%
+57.67K
+430.78%
Mar 31, 2025
UBS Financial Services, Inc.
41.13K
0.11%
+40.06K
+3765.23%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.02%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proportion0.02%
Dimensional US Core Equity 1 ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
